These findings support the concept of an additional pathogenic mechanism in MCAD deficiency, whereby the loss of MCAD may directly disrupt the OXPHOS supercomplex, resulting in secondary OXPHOS defects and mitochondrial respiratory dysfunction. Here, ACADM is linked to medium chain acyl-CoA dehydrogenase deficiency.